A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Respiratory Specialists, Wyomissing

Helene A. Emsellem, MD PC, Chevy Chase

Children's Hospital of the King's Daughters, Norfolk

Clinical Research of Gastonia, Gastonia

Research Carolina Elite, Denver

Bogan Sleep Consultants, Columbia

Lowcountry Lung Critical Care, North Charleston

Medical University of South Carolina, Charleston

IACT Health, Lawrenceville

Clinical Research Institute, Stockbridge

NeuroTrials Research Inc, Atlanta

The Neuro Center, Gainesville

Sleep Practitioners, LLC, Macon

IACT Health, Rincon

Florida Pediatric Research Institute, Winter Park

Florida Pulmonary Research Institute, LLC, Winter Park

Sleep Medicine Specialists of South Florida, PA, Miami

Ivetmar Medical Group, LLC, Miami

Meris Clinical Research, Brandon

Teradan Clinical Trials, Brandon

St. Francis Medical Institute, Clearwater

PDS Research, Kissimmee

Sleep Disorders Center o f Alabama, Birmingham

Ohio Sleep Medicine Institute, Dublin

Cleveland Clinic, Sleep Disorders Center, Cleveland

Ohio Sleep Medicine Institute, Canton

CTI Clinical Research Center, Cincinnati

Intrepid Research, LLC, Cincinnati

Clinical Neurophysiology Services, Sterling Heights

Bronson Sleep Health, Portage

St Lukes Hospital, Sleep Medicine & Research Center, Chesterfield

Clayton Sleep Institute, St Louis

Sleep Therapy & Research Center, San Antonio

Roadrunner Research, San Antonio

FutureSearch Trials of Neurology, Austin

Santa Monica Clinical Trials, Los Angeles

Pacific Research Network, Inc., San Diego

SDS Clinical Trials Inc., Santa Ana

Southern California Institute for Respiratory Diseases, Inc., Los Angeles

Medical Arts Health Research Group, Kelowna

Jodha Tishon Inc, Toronto